Despite the boom in genetic tests available in US laboratories, oversight remains patchy. A survey of laboratory directors suggests that mandatory proficiency testing would result in fewer errors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Gene Tests. http://www.genetests.org/
Kan, Y.K. et al. Polymorphism of DNA Sequence adjacent to human-globin structural gene: relationship to sickle mutation. Proc. Natl. Acad. Sci. USA 75, 5631–5365 (1978).
Frost & Sullivan, U.S. Genetic Diagnostics Markets, F463–552 (2005).
United States Code, Title 42, Section 263(a).
Hofgartner, W.T. & Tait, J.T. Frequency of problems during clinical molecular genetic testing. Am. J. Clin. Pathol. 112, 14–21 (1999).
McGovern, M.M. et al. Quality assurance in molecular genetic testing laboratories. J. Am. Med. Assoc. 281, 835–840 (1999).
Bonini P. et al. Errors in laboratory medicine. Clin Chem., 48, 691–698 (2002).
Witte, D.L. et al. Errors, mistakes blunders, outliers, or unacceptable results: how many? Clin. Chem. 43, 1352–1356 (1997).
Howanitz, P.J. Errors in laboratory medicine: practical lessons to improve patient safety. Arch. Pathol. Med. 129, 1252–1261 (2005).
Hollensead, S.C. et al. Errors in pathology and laboratory medicine: consequences and prevention. J. Surg. Oncol. 88, 161–181 (2004).
Federal Register, vol. 65, p. 25,928, May 4, 2000.
Federal Register, vol. 71, p. 22,595, April 24, 2006.
H.R. Rep. No. 100–899 (1988).
At Home DNA Tests: Marketing Scam or Medical Breakthrough? (Testimony of Thomas Hamilton, Director, Survey and Certification Group, Centers for Medicare and Medicaid Services) Before the Senate Special Committee on Aging, 109th Cong. (2006).
Association for Molecular Pathology (AMP). Membership Directory (AMP. Rockville, MD, 2005).
New York State Department of Health. Database of clinical laboratories currently holding a New York State Department of Health permit in the specified category of testing (2005). Genetic testing/biochemistry. http://www.wadsworth.org/labcert/clep/CategoryPermitLinks/CategoryListing.
New York State Department of Health. Database of clinical laboratories currently holding a New York State Department of Health permit in the specified category of testing (2005). Genetic testing/molecular. http://www.wadsworth.org/labcert/clep/CategoryPermitLinks/CategoryListing.htm
National Tay Sachs and Allied Diseases Association. 2005 Directory: NTSAD Quality Control Program Participating Laboratories (2005). http://www.ntsad.org/pages%5Cqclabs2005.htm
Canavan Foundation. Canavan Foundation Directory of Testing Centers (2005). http://www.canavanfoundation.org/screening.php
Washington G-2 Reports. Lab Outreach Buyer's Guide: Providers of Laboratory Outreach Products and Services (Washington G-2 Publications, New York, 2005).
U.S. Department of Veteran's Affairs. Facilities Locator and Directory (2005). http://www1.va.gov/directory/guide/rpt_fac_list.cfm
American Association for Public Opinion Research. Standard Definitions: Final Dispositions of Case Codes and Outcome Rates for Surveys. ed. 4. (AAPOR Lenexa, Kansas, 2006).
Acknowledgements
The Genetics and Public Policy Center is supported at Johns Hopkins University by The Pew Charitable Trusts. The opinions expressed in this report are those of the authors and do not necessarily reflect the views of The Pew Charitable Trusts. The authors are grateful to Linda Bradley, Michele Caggana, Wayne Grody and Michele Schoonmaker for their helpful review of an earlier draft of this manuscript, and to GeneTests for providing their Clinic Directory.
Author information
Authors and Affiliations
Supplementary information
Rights and permissions
About this article
Cite this article
Hudson, K., Murphy, J., Kaufman, D. et al. Oversight of US genetic testing laboratories. Nat Biotechnol 24, 1083–1090 (2006). https://doi.org/10.1038/nbt0906-1083
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0906-1083
This article is cited by
-
Information Sources Used by Oncologists to Understand Multi-marker Tumor Panel Tests for Cancer Patients
Journal of Cancer Education (2021)
-
Physician interpretation of variants of uncertain significance
Familial Cancer (2019)
-
Cost Sharing and Hereditary Cancer Risk: Predictors of Willingness‐to‐Pay for Genetic Testing
Journal of Genetic Counseling (2014)
-
Molecular genetic testing and the future of clinical genomics
Nature Reviews Genetics (2013)
-
Biomarker Development, Commercialization, and Regulation: Individualization of Medicine Lost in Translation
Clinical Pharmacology & Therapeutics (2007)